(1) Background: Little is known about how left ventricular systolic dysfunction (LVSD) affects functional and clinical outcomes in acute ischemic stroke (AIS) patients undergoing thrombolysis; (2) Methods: A retrospective observational study conducted between 2006 and 2018 included 937 consecutive AIS patients undergoing thrombolysis. LVSD was defined as left ventricular ejection fraction (LVEF) < 50%. Univariate and multivariate binary logistic regression analysis was performed for demographic characteristics. Ordinal shift regression was used for functional modified Rankin Scale (mRS) outcome at 3 months. Survival analysis of mortality, heart failure (HF) admission, myocardial infarction (MI) and stroke/transient ischemic attack (TIA) was evaluated with a Cox-proportional hazards model; (3) Results: LVSD patients in comparison with LVEF ≥ 50% patients accounted for 190 and 747 patients, respectively. LVSD patients had more comorbidities including diabetes mellitus (100 (52.6%) vs. 280 (37.5%), p < 0.001), atrial fibrillation (69 (36.3%) vs. 212 (28.4%), p = 0.033), ischemic heart disease (130 (68.4%) vs. 145 (19.4%), p < 0.001) and HF (150 (78.9%) vs. 46 (6.2%), p < 0.001). LVSD was associated with worse functional mRS outcomes at 3 months (adjusted OR 1.41, 95% CI 1.03–1.92, p = 0.030). Survival analysis identified LVSD to significantly predict all-cause mortality (adjusted HR [aHR] 3.38, 95% CI 1.74–6.54, p < 0.001), subsequent HF admission (aHR 4.23, 95% CI 2.17–8.26, p < 0.001) and MI (aHR 2.49, 95% CI 1.44–4.32, p = 0.001). LVSD did not predict recurrent stroke/TIA (aHR 1.15, 95% CI 0.77–1.72, p = 0.496); (4) Conclusions: LVSD in AIS patients undergoing thrombolysis was associated with increased all-cause mortality, subsequent HF admission, subsequent MI and poorer functional outcomes, highlighting a need to optimize LVEF.
Out-of-hospital cardiac arrests (OHCAs) occurring in high-rise buildings are a challenge to Emergency Medical Services (EMS). Contemporary EMS guidelines lack specific recommendations for systems and practitioners regarding the approach to these patients. This scoping review aimed to map the body of literature pertaining to OHCAs in high-rise settings in order to clarify concepts and understanding and to identify knowledge gaps. Databases were searched from inception through to 6 May 2021 including OVID Medline, PubMed, Embase, CINAHL, and Scopus. Twenty-three articles were reviewed, comprising 8 manikin trials, 14 observational studies, and 1 mathematical modelling study. High-rise settings commonly have lower availability of bystanders and automatic external defibrillators (AEDs), while height constraints often lead to delays in EMS interventions and suboptimal cardiopulmonary resuscitation (CPR), scene access, and extrication. Four studies found return of spontaneous circulation (ROSC) rates to be significantly poorer, while seven studies found rates of survival-to-hospital discharge (n = 3) and neurologically favourable survival (n = 4) to be significantly lower in multistorey settings. Mechanical chest compression devices, transfer sheets, and strategic defibrillator placement were suggested as approaches to high-rise OHCA management. A shift to maximising on-scene treatment time, along with bundling novel prehospital interventions, could ameliorate some of these difficulties and improve clinical outcomes for patients.
1 December 2021 in The American Journal of Cardiology
Objectives: Severe mitral regurgitation (MR) has been associated with significant morbidity and mortality, necessitating effective risk stratification. The H2FPEF score has demonstrated prognostic value in other cardiac disorders. This study evaluates the prognostic utility of a modified version of the H2FPEF score for severe MR with preserved ejection fraction. Methods and Results: Patients from a tertiary cardiovascular referral center with consecutive index echocardiographic diagnoses of severe MR were included. We excluded patients with secondary MR, reduced LVEF ( 25 kg/m2) as opposed to the original cutoff (BMI > 30 kg/m2). Patients were stratified based on the modified score into low (0–1), intermediate (2–5), and high (6–9) groups. The primary endpoint, a composite of all-cause mortality and first heart failure hospitalization (HFH), was analyzed using multivariate Cox regression. A total of 388 patients (low 57 [14.7%]; intermediate 218 [56.2%]; high 113 [29.1%] modified H2FPEF score) were included with a median follow-up duration of 4.53 years (interquartile range 2.61 to 6.60). Patients with a high modified H2FPEF score were older, more likely to have hyperlipidemia, diabetes, end-stage renal disease, higher NYHA class, and lower LVEF. Malay ethnicity, hyperlipidemia, diabetes, end-stage renal disease and a higher indexed left atrial diameter were independently associated with greater modified H2FPEF score. High and intermediate modified H2FPEF scores were associated with the primary endpoint (HR 9.17, 95% CI 2.15–39.1 and 6.71, 95% CI 1.62–27.9 respectively) versus low scores. However, a Fine–Gray regression showed no difference in subdistribution hazards of first HFH between high and intermediate scores. Conclusions: The modified H2FPEF score may facilitate risk stratification for all-cause mortality and first HFH in patients with severe primary MR and preserved ejection fraction.
About Me
Internal Medicine Resident from Singapore
Keen interest in internal medicine, Cardiology and Public Health
Internal Medicine Resident from Singapore
Keen interest in internal medicine, Cardiology and Public Health